Xlumena, Inc.

Xlumena is the leader in the development of image-guided therapeutic endoscopy products, specializing in advanced implants and devices for a new, rapidly growing field of medicine. Collaborating with top physicians in the field, Xlumena focuses on technologies that advance therapy to the next level. These innovations may enable numerous translumenal therapeutic procedures, helping transform complex surgeries into outpatient events.

In The News

Boston Scientific Agrees to Acquire Xlumena

XLumena Secures $1,168,669 New Funding Round (April 9, 2013)

Current Investors/Backers

Xlunena, Inc. is backed by a group of top tier investors including Prism VentureWorks, Charter Life Sciences, Ascent Biomedical Ventures and Aperture Venture Partners.

For more information on Xlumena, Inc., please visit their web site at www.xlumena.com .

ATEL VENTURE PORTFOLIO NEWS

ATEL Portfolio News